COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

被引:143
作者
Chi, Wei-Yu [1 ]
Li, Yen-Der [2 ]
Huang, Hsin-Che [3 ]
Chan, Timothy En Haw [4 ,5 ,6 ]
Chow, Sih-Yao [7 ]
Su, Jun-Han [2 ]
Ferrall, Louise [8 ]
Hung, Chien-Fu [8 ,9 ,10 ]
Wu, T-C [8 ,9 ,10 ,11 ,12 ]
机构
[1] Weill Cornell Med, Physiol Biophys & Syst Biol Grad Program, New York, NY USA
[2] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[3] Mem Sloan Kettering Canc Ctr, Triinst PhD Program Chem Biol, 1275 York Ave, New York, NY 10021 USA
[4] Max Planck Inst Immunobiol & Epigenet, Int Max Planck Res Sch Immunobiol Epigenet & Meta, Freiburg, Germany
[5] Univ Freiburg, Med Ctr, Dept Urol, Freiburg, Germany
[6] Univ Freiburg, Fac Biol, Freiburg, Germany
[7] EirGenix Inc, Downstream Proc Sci, Hsinchu, Taiwan
[8] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA
[9] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA
[10] Johns Hopkins Univ, Dept Obstet & Gynecol, Baltimore, MD 21218 USA
[11] Johns Hopkins Univ, Dept Microbiol & Immunol, Baltimore, MD 21218 USA
[12] Johns Hopkins Med Inst, CRB 2 Room 309,1550 Orleans St, Baltimore, MD 21231 USA
关键词
COVID-19; Vaccine; Immunity; Variant; SARS-CoV-2; MESSENGER-RNA; BNT162B2; VACCINE; CHADOX1; NCOV-19; NEUTRALIZING ANTIBODY; OMICRON VARIANT; NON-INFERIORITY; UNITED-STATES; SINGLE-BLIND; IMMUNOGENICITY; SAFETY;
D O I
10.1186/s12929-022-00853-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Coronavirus Disease 2019 (COVID-19) has been the most severe public health challenge in this century. Two years after its emergence, the rapid development and deployment of effective COVID-19 vaccines have successfully controlled this pandemic and greatly reduced the risk of severe illness and death associated with COVID-19. However, due to its ability to rapidly evolve, the SARS-CoV-2 virus may never be eradicated, and there are many important new topics to work on if we need to live with this virus for a long time. To this end, we hope to provide essential knowledge for researchers who work on the improvement of future COVID-19 vaccines. In this review, we provided an up-to-date summary for current COVID-19 vaccines, discussed the biological basis and clinical impact of SARS-CoV-2 variants and subvariants, and analyzed the effectiveness of various vaccine booster regimens against different SARS-CoV-2 strains. Additionally, we reviewed potential mechanisms of vaccine-induced severe adverse events, summarized current studies regarding immune correlates of protection, and finally, discussed the development of next-generation vaccines.
引用
收藏
页数:27
相关论文
共 291 条
[81]  
Ema, 2021, EMA ECDC RECOMMENDAT
[82]  
Ema, 2021, COMIRNATY SPIKEVAX E
[83]   Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial [J].
Emary, Katherine R. W. ;
Golubchik, Tanya ;
Aley, Parvinder K. ;
Ariani, Cristina, V ;
Angus, Brian ;
Bibi, Sagida ;
Blane, Beth ;
Bonsall, David ;
Cicconi, Paola ;
Charlton, Sue ;
Clutterbuck, Elizabeth A. ;
Collins, Andrea M. ;
Cox, Tony ;
Darton, Thomas C. ;
Dold, Christina ;
Douglas, Alexander D. ;
Duncan, Christopher J. A. ;
Ewer, Katie J. ;
Flaxman, Amy L. ;
Faust, Saul N. ;
Ferreira, Daniela M. ;
Feng, Shuo ;
Finn, Adam ;
Folegatti, Pedro M. ;
Fuskova, Michelle ;
Galiza, Eva ;
Goodman, Anna L. ;
Green, Catherine M. ;
Green, Christopher A. ;
Greenland, Melanie ;
Hallis, Bassam ;
Heath, Paul T. ;
Hay, Jodie ;
Hill, Helen C. ;
Jenkin, Daniel ;
Kerridge, Simon ;
Lazarus, Rajeka ;
Libri, Vincenzo ;
Lillie, Patrick J. ;
Ludden, Catherine ;
Marchevsky, Natalie G. ;
Minassian, Angela M. ;
McGregor, Alastair C. ;
Mujadidi, Yama F. ;
Phillips, Daniel J. ;
Plested, Emma ;
Pollock, Katrina M. ;
Robinson, Hannah ;
Smith, Andrew ;
Song, Rinn .
LANCET, 2021, 397 (10282) :1351-1362
[84]   Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2 [J].
Evans, John P. ;
Zeng, Cong ;
Qu, Panke ;
Faraone, Julia ;
Zheng, Yi-Min ;
Carlin, Claire ;
Bednash, Joseph S. ;
Zhou, Tongqing ;
Lozanski, Gerard ;
Mallampalli, Rama ;
Saif, Linda J. ;
Oltz, Eugene M. ;
Mohler, Peter J. ;
Xu, Kai ;
Gumina, Richard J. ;
Liu, Shan-Lu .
CELL HOST & MICROBE, 2022, 30 (08) :1093-+
[85]   A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: An interim analysis in Indonesia [J].
Fadlyana, Eddy ;
Rusmil, Kusnandi ;
Tarigan, Rodman ;
Rahmadi, Andri Reza ;
Prodjosoewojo, Susantina ;
Sofiatin, Yulia ;
Khrisna, Citra, V ;
Sari, Rini Mulia ;
Setyaningsih, Lilis ;
Surachman, Fikrianti ;
Bachtiar, Novilia Sjafri ;
Sukandar, Hadyana ;
Megantara, Imam ;
Murad, Chrysanti ;
Pangesti, Krisna Nur A. ;
Setiawaty, Vivi ;
Sudigdoadi, Sunarjati ;
Hu, Yaling ;
Gao, Qiang ;
Kartasasmita, Cissy B. .
VACCINE, 2021, 39 (44) :6520-6528
[86]   Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine [J].
Falsey, Ann R. ;
Sobieszczyk, Magdalena E. ;
Hirsch, Ian ;
Sproule, Stephanie ;
Robb, Merlin L. ;
Corey, Lawrence ;
Neuzil, Kathleen M. ;
Hahn, William ;
Hunt, Julie ;
Mulligan, Mark J. ;
McEvoy, Charlene ;
DeJesus, Edwin ;
Hassman, Michael ;
Little, Susan J. ;
Pahud, Barbara A. ;
Durbin, Anna ;
Pickrell, Paul ;
Daar, Eric S. ;
Bush, Larry ;
Solis, Joel ;
Carr, Quito Osuna ;
Oyedele, Temitope ;
Buchbinder, Susan ;
Cowden, Jessica ;
Vargas, Sergio L. ;
Benavides, Alfredo Guerreros ;
Call, Robert ;
Keefer, Michael C. ;
Kirkpatrick, Beth D. ;
Pullman, John ;
Tong, Tina ;
Isaacs, Margaret Brewinski ;
Benkeser, David ;
Janes, Holly E. ;
Nason, Martha C. ;
Green, Justin A. ;
Kelly, Elizabeth J. ;
Maaske, Jill ;
Mueller, Nancy ;
Shoemaker, Kathryn ;
Takas, Therese ;
Marshall, Richard P. ;
Pangalos, Menelas N. ;
Villafana, Tonya ;
Gonzalez-Lopez, Antonio .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (25) :2348-2360
[87]   SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 [J].
Falsey, Ann R. ;
Frenck, Robert W., Jr. ;
Walsh, Edward E. ;
Kitchin, Nicholas ;
Absalon, Judith ;
Gurtman, Alejandra ;
Lockhart, Stephen ;
Bailey, Ruth ;
Swanson, Kena A. ;
Xu, Xia ;
Koury, Kenneth ;
Kalina, Warren ;
Cooper, David ;
Zou, Jing ;
Xie, Xuping ;
Xia, Hongjie ;
Tuereci, Ozlem ;
Lagkadinou, Eleni ;
Tompkins, Kristin R. ;
Shi, Pei-Yong ;
Jansen, Kathrin U. ;
Sahin, Ugur ;
Dormitzer, Philip R. ;
Gruber, William C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17) :1627-1629
[88]   Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection [J].
Feng, Shuo ;
Phillips, Daniel J. ;
White, Thomas ;
Sayal, Homesh ;
Aley, Parvinder K. ;
Bibi, Sagida ;
Dold, Christina ;
Fuskova, Michelle ;
Gilbert, Sarah C. ;
Hirsch, Ian ;
Humphries, Holly E. ;
Jepson, Brett ;
Kelly, Elizabeth J. ;
Plested, Emma ;
Shoemaker, Kathryn ;
Thomas, Kelly M. ;
Vekemans, Johan ;
Villafana, Tonya L. ;
Lambe, Teresa ;
Pollard, Andrew J. ;
Voysey, Merryn .
NATURE MEDICINE, 2021, 27 (11) :2032-+
[89]  
Ferdinands JM, 2022, MMWR-MORBID MORTAL W, V71, P255, DOI 10.15585/mmwr.mm7107e2
[90]   Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) [J].
Flaxman, Amy ;
Marchevsky, Natalie G. ;
Jenkin, Daniel ;
Aboagye, Jeremy ;
Aley, Parvinder K. ;
Angus, Brian ;
Belij-Rammerstorfer, Sandra ;
Bibi, Sagida ;
Bittaye, Mustapha ;
Cappuccini, Federica ;
Cicconi, Paola ;
Clutterbuck, Elizabeth A. ;
Davies, Sophie ;
Dejnirattisai, Wanwisa ;
Dold, Christina ;
Ewer, Katie J. ;
Folegatti, Pedro M. ;
Fowler, Jamie ;
Hill, Adrian V. S. ;
Kerridge, Simon ;
Minassian, Angela M. ;
Mongkolsapaya, Juthathip ;
Mujadidi, Yama F. ;
Plested, Emma ;
Ramasamy, Maheshi N. ;
Robinson, Hannah ;
Sanders, Helen ;
Sheehan, Emma ;
Smith, Holly ;
Snape, Matthew D. ;
Song, Rinn ;
Woods, Danielle ;
Screaton, Gavin ;
Gilbert, Sarah C. ;
Voysey, Merryn ;
Pollard, Andrew J. ;
Lambe, Teresa .
LANCET, 2021, 398 (10304) :981-990